LRI Validation Suite Meeting September 06, 2011. Agenda Test data update – Selection of core message set Update Review validation discussion page – Mapping.

Slides:



Advertisements
Similar presentations
Reflex, Confirmatory and Add-on Testing
Advertisements

LRI Validation Suite Meeting August 16, Agenda Review of LRI Validation Suite Charter/Overview Acquiring test data update Review of proposed test.
LRI/LOI Pilots May 1, Participants Coordination of Effort Validation Suite Vocabulary Group Implementation Guide Analysis Support Team Others.
S&I Framework Testing HL7 V2 Lab Results Interface and RI Pilot Robert Snelick National Institute of Standards and Technology June 23 rd, 2011 Contact:
Orchard Harvest™ LIS Review Results Training
Result Status Relationships
1 Work Plan for Testing the LIS and EHR Systems Define Test Flow based from Work Flow Define a testing methodology Develop high-level requirements for.
CPT Pathology and Laboratory
© 2008 Health Level Seven ®, Inc. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven, Inc. Reg. U.S. Pat &
LRI Validation Suite Meeting November 1st, Agenda Review of LIS Test Plan Template CLIA Testing EHR testing (Juror Document)—Inspection Testing.
LRI Validation Suite Meeting November 15th, 2011.
LRI Validation Suite LRI Validation Suite Meeting Rob Snelick—NIST April 24th, 2012.
ALOINC Order Code Project: Public Health Test Orders Ruby M. Phelps September 24, 2014 Laboratory Practice Standards Branch Division of Laboratory Programs,
Anatomy of a Lab Test EHR Laboratory Package for Small Sites without a Laboratory Professional Resource Patient Management System.
S&I Framework LRI Validation Suite Vocabulary Testing Proposal (Lab Results Interface) Robert Snelick National Institute of Standards and Technology October.
HS225 Medical coding i Seminar 8.
2015 User Conference Diagnostic Tests in OP14 April 23 & 24, 2015 Presented by: BJ Bloom, EHR Training Specialist Jan Crosser, EHR Training Specialist.
LRI Validation Suite LRI Validation Suite Meeting Rob Snelick—NIST March 27th, 2012.
© 2008 Health Level Seven ®, Inc. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven, Inc. Reg. U.S. Pat &
LRI Validation Suite Meeting November 8th, Agenda Review of LIS Test Plan Template – Follow-up; Questions Review of EHR Test Plan – EHR Pre-test.
LRI Validation Suite LRI Prototype Tool Demonstration Rob Snelick—NIST January 31st, 2011.
LRI Validation Suite WG Update for LRI Pilot WG May 1, 2012.
Unit 8 Presentation Chapter 17
Query Health Operations Workgroup HQMF & QRDA Query Format - Results Format February 9, :00am – 12:00am ET.
1 Health Level Seven (HL7) Report Out Population Science and Structured Documents Workgroup (SDWG) Riki Ohira September 22, 2011.
LRI Validation Suite Meeting September 20, Agenda Action Item List Test data update – Selection of core message set – NIST data sets and management.
LRI Validation Suite Meeting October 11th, Agenda (Red=topics today) Action Item List Test data update – Selection of core message set – Review.
Indian Health Service Laboratory Modernization LOINC/UCUM Proposed Strategy Clarence Smiley David Gifford.
Common Laboratory Tests. Let’s look at some nuances of 3 of most commonly ordered lab tests CBC (Complete Blood Count) BMP (Basic Metabolic Panel) Coagulation.
Complete Blood Count.
EHR-S Functional Requirements IG: Lab Results Interface Laboratory Initiative.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 15, 2011.
LRI Validation Suite Meeting October 4th, Agenda Action Item List Test data update – Selection of core message set – Review of lab results test.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care State Pilots: Adding Clinical Data to Administrative Data Roxanne.
Anatomic Pathology Reporting Challenge Reporting methods over HL7 transactions vary significantly by vendor –Result Segment(s) -- OBXs –Note Segment(s)
Fifth Annual President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting September , 2007 Thomas J. Spira, M.D. International Laboratory.
Clinical Laboratory Studies
BMP Date: McIntyre, Kim MRN Time : LabValueReference Range Glucose125 mg/dL mg/dL Calcium9.8 mg/dL8.9 – 10.3 mg/dL Potassium3.5 mEq/L3.6.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Adding Clinical Data to Administrative Data: AHRQ-sponsored.
MATT REID JULY 28, 2014 CCDA Usability and Interoperability.
LRI Validation Suite Meeting September 27, Agenda Action Item List Test data update – Selection of core message set – Review of lab results test.
S&I PUBLIC HEALTH REPORTING INITIATIVE: DEVELOPING OF A TEAMING APPROACH S&I Public Health Reporting Initiative Nikolay Lipskiy, MD, DrPH, Co-Lead September,
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 1, 2011.
S&I Framework LRI Validation Suite Vocabulary Testing Proposal (Lab Results Interface) Robert Snelick National Institute of Standards and Technology February.
Lab Results Interface Validation Suite WG July 28, 2011.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting May 9, 2011.
Lab and Messaging CoP 11/29/2012. Agenda Agenda review Introduction to the Specimen Cross-Mapping Table (Specimen CMT) – Background – Expected uses –
12/24/2015DRAFT1 Public Health & Lab LOINC - June 8 th 2012 CDC Vocabulary Team Office of Surveillance, Epidemiology and Laboratory Services (OSELS)
LRI Validation Suite Meeting Prototype Tool Demonstration December 20th, 2011.
LOINC (UNIVERSAL) ORDER CODES SINGLE TEST LIST Quest Diagnostics Review July 2014.
Laboratory Pilots/Deployment June 26, Participants Coordination of Effort Validation Suite Vocabulary Group Implementation Guide Analysis LRI/LOI/eDOS.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 29, 2011.
EDOS Workgroup Update Laboratory Orders Interface Initiative.
Lab Results Interface Validation Suite Workgroup and Pilots Workgroup Vision, Charter, NIST Collaboration, July 8,
Clinical Laboratory Review for Toxicology
Pathology & Laboratory By Alejandra Munoz, CPC, NCICS.
Implementation of National Standards (LOINC, SNOMED) for Electronic Reporting of Laboratory Results: BioSense Experience Nikolay Lipskiy 1, DrPH, MS, MBA;
Unit 3 Seminar.  Lab tests  Laboratory codes describe the performance of lab tests  A specimen includes:  Tissue (e.g. blood and urine)  The CPT.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting November 21, 2011.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting September 12, 2011.
Labs Early Adoption Program Template Insert the Name of Your Implementation / Organization Here MM/DD/YYYY.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting July 18, 2011.
Microbiology Discrete Results Reporting Presenters: Tymn Neece Sonal Pandey Lancaster General Hospital Lancaster, Pa.
Labs Early Adoption Program Template Insert the Name of Your Implementation / Organization Here MM/DD/YYYY.
Laboratory Orders Interface Initiative
Diagnostic Tests Diagnostics Chapter 6
Basic laboratory testing
Diagnostic Services in Healthcare
Basic laboratory testing
Presentation transcript:

LRI Validation Suite Meeting September 06, 2011

Agenda Test data update – Selection of core message set Update Review validation discussion page – Mapping lab results and LOINC Review of EHR Test Plan Template Update on LIS Test Plan Template Face-to-Face Questionnaire NIST/LMCO meeting Tooling Juror Document/Spreadsheet Analysis – Identify other MU requirements we can leverage (e.g., usability) – Mapping CLIA requirements to HL7 Elements – Identifying Reportable Conditions to PH Lab Results Planning

Categorization of Tests The 144 individual tests in the final version of the list can be clinically organized into six clinical lab test categories. These are: 1)Common Hematology tests (16), 2)Urinalysis test (1), 3)Common Chemistry tests (34), 4)Special Chemistry tests (27), 5)Microbiology tests (50), plus antibiotic susceptibility tests (7), and 6)Other Clinical Lab tests (9).

20 Common Tests 1.CBC and WBC Differential/Morphology, 2.Urinalysis, and 3.Comprehensive Metabolic Panel (CMP) – Quest Diagnostics Directory of Services and Specimen Collection Guide of May, 2008 the CMP included 17 items: – Calcium; BUN; Creatinine; BUN/Creatinine Ratio (a calculated value); Total Protein; Albumin; Globulin; Albumin/Globulin Ratio (a calculated value); Bilirubin, Total; Glucose; Alkaline Phosphatase; AST; ALT; Sodium; Potassium; Chloride; CO2.

LOINC-RELMA List for Hemoglobin LOINC #ComponentProperty Time Aspect SystemScale Ex. UCUM UnitsEx. UnitsClassLong Common Name Order/ObsType Oxyhemoglobin/Hemoglobin.totalMFrPtBldQn %CHEMFractional oxyhemoglobin in Blood Observation Oxyhemoglobin/Hemoglobin.totalMFr8H^maxBldAQn %PULMFractional oxyhemoglobin in 8 hour maximum Arterial blood Oxyhemoglobin/Hemoglobin.totalMFr8H^minBldAQn %PULMFractional oxyhemoglobin in 8 hour minimum Arterial blood Oxyhemoglobin/Hemoglobin.totalMFrPtBld.preductalQn% %PULMFractional oxyhemoglobin in Blood Preductal Oxyhemoglobin/Hemoglobin.totalMFrPtBld.postductalQn% %PULMFractional oxyhemoglobin in Blood Postductal Oxyhemoglobin/Hemoglobin.totalMFrPtBldAQn %CHEMFractional oxyhemoglobin in Arterial blood Observation Oxyhemoglobin/Hemoglobin.totalMFrPtBldCQn %CHEMFractional oxyhemoglobin in Capillary blood Observation Oxyhemoglobin/Hemoglobin.totalMFrPtBldVQn %CHEMFractional oxyhemoglobin in Venous blood Observation Oxyhemoglobin/Hemoglobin.totalMFrPtPlasQn %CHEMFractional oxyhemoglobin in Plasma Observation Oxyhemoglobin/Hemoglobin.totalMFrPtBldCoVQn % of totCHEMFractional oxyhemoglobin in Venous cord blood Observation Oxyhemoglobin/Hemoglobin.totalMFrPtBldCoAQn % of totCHEMFractional oxyhemoglobin in Arterial cord blood Observation Oxyhemoglobin/Hemoglobin.totalMFrPtBldMVQn % of totCHEMFractional oxyhemoglobin in Mixed venous blood Observation1 No Method listed in RELMA for any of these tests

Testing Options/Policy LOINC #ComponentProperty Time Aspect SystemScaleEx. UCUM Units Ex. UnitsClassLong Common NameOrder/Obs Type Oxyhemoglobin/Hemoglobin.totalMFrPtBldQn% %CHEMFractional oxyhemoglobin in BloodObservation Oxyhemoglobin/Hemoglobin.totalMFr8H^maxBldAQn% %PULMFractional oxyhemoglobin in 8 hour maximum Arterial blood Oxyhemoglobin/Hemoglobin.totalMFr8H^minBldAQn% %PULMFractional oxyhemoglobin in 8 hour minimum Arterial blood 2 OBR|1|111325^EHR^ ^ISO| ^Lab^ ^ISO|718- 7^Hemoglobin^LN||| |||||||||100^Hippocrates^Harold|||||| ||CH| F|NA&Not Applicable&LB OBX|1|NM| ^Hemoglobin.Total^LN||^12.4|g/dL^grams per deciliter^UCUM|12.0 to 16.0||||F||| |||||||||Effective Labs, Inc^^^^^DRSD& &ISO^XX^^^6543|3434 Test Loop^^Ann Arbor^MI^48103^^B Depending on what the order is, what are possible test results? Are there more than one valid test result base on local conventions, etc.? Potential Test Case Policy: In the data sheet (test case) we can allow any of these to be selected. This assumes that nothing else in the message needs to be changed. It would be an easy way to provide the capability to tests all of these LOINC codes with minimal effort. The Long Common Name is the differentiator. One of the determining factors likely will be whether or not the same result value can be used for all of the various versions of Oxyhemoglobin/Hemoglobin.total. Issues/Comments: Other data elements in the HL7 message might also need to be test-specific. For example, if data for the SPM-4: Specimen Type and SPM-8: Specimen Source are included in the message, then the same message probably could not be used for all of the versions of Oxyhemoglobin/Hemoglobin.total. OBX-7: Reference Range also might be a limiting factor if venous blood and arterial blood result values have normal ranges that don’t overlap. The LOINC code is the anchor that discretely and accurately identifies the lab test that was ordered/performed. No matter what a hospital or physician chooses to call the test, the LOINC code is the one constant that tells everyone which it test was. For our purposes, we’ll need to be sure that all of the data for the data elements in the HL7 message are appropriate for the test indicated by the LOINC code.

Reporting Format Requirement 1.Tests and/or components with numeric results, units, and normal ranges 2.Tests and/or components with a limited set of textual results with or without normal ranges 1.positive/negative/indeterminate, resistant/intermediate/susceptibility 2.cytology / anatomic pathology 3.mutation type and location 4.organism name 3.Tests with defined structure in Observation Result Segment OBX-3 through OBX-8 for the reporting of Culture Results and Antimicrobial Sensitivities 4.Semi Structured or Unstructured components or results Tests and/or components reported in a PDF or data blob 1.The 4th reporting format may be utilized in the cases where structured data does not apply (e.g. images).

Note on the use of LOINC The list of tests has been organized by order panel or, for micro related tests, by target organism for easier readability. The LOINC terms included here are considered examples only – though they may be the more common LOINC terms, each laboratory needs to be sure to map their own tests to the most appropriate LOINC, even if it is NOT on this list. This is NOT an exclusive list of LOINC terms – ANY valid LOINC should be accepted in data exchange projects based on this specification.

Action List: Initial Set of Test Data Select at least one test from first 5 clinical test categories – Category 6 is “others” Include: – CBC and WBC Differential/Morphology, (2 results) – Urinalysis, and (1 result) – Comprehensive Metabolic Panel (CMP) (17 Results) Include test to cover the 4 (3 ??) reporting formats – However, the second format is not in the test list Create coverage mapping table of tests/LOINC codes – Results (1 to many LOINC codes—how do we handle, document?) Get sample messages – Example from IG – NIST Related set of test data – Messages to be verified Finish test case for one simple message

Examples From IG LEAD LABORATORY RESULT MESSAGE CAMPYLOBACTER JEJUNI ANIMAL RABIES HEPATITIS C VIRUS Example: Minimal Message Culture Results – stool culture – Three pathogens: Campylobacter jejuni, Salmonella and Shigella. Examples of Culture and Susceptibility Results LINKING PARENT AND CHILD RESULTS

LEAD LABORATORY RESULT MESSAGE MSH|^~\&|Lab1^1234^CLIA|^1234^CLIA|ELR^ ^ISO|SPH^ ^ISO| ||ORU^R01^ORU_R01| |P^T|2.5.1|||NE|NE|USA||||USELR1.0^^ ^ISO SFT|1|Level Seven Healthcare Software, Inc.^L^^^^& ^ISO^XX^^^1234|1.2|An Lab System|56734|| PID|1|| ^^^MPI& &ISO^MR^A& &ISO~ ^^^& ^ISO^SS||Everyman^Adam^A^^^^L^^^^^^^BS|Mum^Martha^M^^^^M| |M|| ^White^CDCREC^^^^04/24/2007|2222 Home Street^^Ann Arbor^MI^99999^USA^H||^PRN^PH^^1^555^ |^WPN^PH^^1^955^ |eng^English^ISO6392^^^^3/29/2007|M^Marrie d^HL70002^^^^2.5.1||||||N^Not Hispanic or Latino^HL70189^^^^2.5.1||||||||N||| |Reliable^ ^ISO NK1|1|Mum^Martha^M^^^^L|MTH^Mother^HL70063^^^^2.5.1| 444 Home Street^Apt B^Ann Arbor^MI^99999^USA^H|^PRN^PH^^1^555^ PV1|1|O|4E^234^A^Good Health Hospital& &ISO^N^N^Building 1^4^Nursing unit 4 East^1234&& &ISO^& &ISO|R|||||||||||||||||||||||||||||||||||||||| | PV2|||1^Sick^99AdmitReason|||||||||||||N||||||||Level Seven Healthcare, Inc.^L^^^^& ^ISO^XX^^^1234||| ||| ORC|RE|23456^EHR^ ^IS O| ^Lab^ ^ISO|||||||||1234^Admit^Alan^A^III^Dr^^^& ^ISO^L^^^EI^& ^ISO^^^^^^^^MD||^WPN^PH^^1^555^ |||||||Level Seven Healthcare, Inc.^L^^^^& ^ISO^XX^^^1234|1005 Healthcare Drive^^Ann Arbor^MI^99999^USA^B|^WPN^PH^^1^555^ |4444 Healthcare Drive^Suite 123^Ann Arbor^MI^99999^USA^B OBR|1|23456^EHR^ ^ISO| ^Lab^ ^ISO| ^Lead BldC- mCnc^LN^ ^Blood lead test^99USI^2.24||| ||||||diarrhea|||1234^Admit^Alan^A^III^Dr^^^& ^ISO^L^^^EI^& ^ISO^^^^^^ ^^MD|^WPN^PH^^1^555^ ||||| |||F||||||787.91^ DIARRHEA^I9CDX^^^^07/09/2008|1235&Slide&Stan&S&&Dr&MD&&DOC& &ISO OBX|1|NM| ^Lead BldC-mCnc^LN^^^^2.24|1|50|ug/dL^micro-gram per deci-liter^UCUM^^^^1.6|<10 ug/dL|H|||F||| ||||| ||||Lab^L^^^^CLIA& &ISO^XX^^^1236|3434 Industrial Loop^^Ann Arbor^MI^99999^USA^B| ^Slide^Stan^S^^^^^NPPES& &ISO^L^^^NPI SPM|1|23456&EHR& &ISO^ &Lab& &ISO|| ^Capillary blood specimen^SCT^BLDC^Blood capillary^HL70070^ ^2.5.1||HEPA^Ammonium heparin^HL70371^^^^2.5.1|CAP^Capillary Specimen^HL70488^^^^2.5.1| ^Venous structure of digit^SCT^^^^ |||P^Patient^HL60369^^^^2.5.1|50^uL&MicroLiter&UCUM&&&&1.6||||| | OBX|2|NM| ^Age at specimen collection^LN^^^^2.24||3|a^year^UCUM^^^^1.6|||||F||| ||||| ||||Lab^L^^^^CLIA& &ISO^XX^^^1236|3434 Industrial Loop^^Ann Arbor^MI^99999^USA^B| ^Slide^Stan^S^^^^^NPPES& &ISO^L^^^NPI

CAMPYLOBACTER JEJUNI MSH|^~\&|Lab1^1234^CLIA|^1234^CLIA|ELR^ ^ISO|SPH^ ^ISO| ||ORU^R01^ORU_R01| |P^T|2.5.1|||NE|NE|USA||||USELR1.0^^ ^ISO SFT|1|Level Seven Healthcare Software, Inc.^L^^^^& ^ISO^XX^^^1234|1.2|An Lab System|56734|| PID|1|| ^^^MPI& &ISO^MR^A& &ISO~ ^^^& ^ISO^SS||Everyman^Adam^A^^^^L^^^^^^^BS|Mum^Martha^M^^^^M| |M|| ^White^CDCREC^^^^04/24/2007|2222 Home Street^^Ann Arbor^MI^99999^USA^H||^PRN^PH^^1^555^ |^WPN^PH^^1^955^ |eng^English^ISO6392^^^^3/29/2007|M^Marrie d^HL70002^^^^2.5.1||||||N^Not Hispanic or Latino^HL70189^^^^2.5.1||||||||N||| | Reliable^ ^ISO PV1|1|O|4E^234^A^Good Health Hospital& &ISO^N^N^Building 1^4^Nursing unit 4 East^1234&& &ISO^& &ISO|R|||||||||||||||||||||||||||||||||||||||| | PV2|||1^Sick^99AdmitReason|||||||||||||N||||||||Level Seven Healthcare, Inc.^L^^^^& ^ISO^XX^^^1234||| ||| ORC|RE|23456^EHR^ ^ISO| ^Lab^ ^ISO|||||||||1234^Admit^Alan^A^III^Dr^ ^^& ^ISO^L^^^EI^& ^ISO^^^^^^^^MD||^WPN^PH^^1^555^ |||||||Level Seven Healthcare, Inc.^L^^^^& ^ISO^XX^^^1234|1005 Healthcare Drive^^Ann Arbor^MI^99999^USA^B|^WPN^PH^^1^555^ |4444 Healthcare Drive^Suite 123^Ann Arbor^MI^99999^USA^B OBR|1|23456^EHR^ ^ISO| ^Lab^ ^ISO|625-4^Bacteria identified^LN^ ^ CULTURE, STOOL^99USI^2.26||| ||||||diarrhea|||1234^Admit^Alan^A^III^Dr^^^& ^ISO^L^^^EI^& ^ISO^^^^^^ ^^MD|^WPN^PH^^1^555^ ||||| |||F||||||787.91^ DIARRHEA^I9CDX^^^^07/09/2008|1235&Slide&Stan&S&&Dr&MD&&DOC& &ISO OBX|1|CWE|625-4^Bacteria identified:Prid:Pt:Stool:Nom:Culture^LN^^^^2.26|1| ^Campylobacter jejuni^SCT^^^^January 2007||||||P||| |||0086^Bacterial identification^OBSMETHOD^^^^ || ||||GHH Lab^L^^^^CLIA& &ISO^XX^^^1236|3434 Industrial Loop^^Ann Arbor^MI^99999^USA^B| ^Slide^Stan^S^^^^^NPPES& &ISO^L^^^NPI SPM|1|23456&EHR& &ISO^ &Lab& &ISO|| ^Stool specimen^SCT^^^^ |||||||P^Patient^HL60369^^^^2.5.1|10^g&gram&UCUM&&&&1.6||||| |

Example: Minimal Message MSH|^~\&|Lab1^1234^CLIA|^1234^CLIA|ELR^ ^ISO|SPH^ ^ISO| ||ORU^R01^ORU_R01| |P^T|2.5.1|||NE|NE|USA||||USELR1.0^^ ^ISO SFT|1|Level Seven Healthcare Software, Inc.^L^^^^& ^ISO^XX^^^1234|1.2|An Lab System|56734|| PID|1|| ^^^MPI& &ISO^MR^A& &ISO~ ^^^& ^ISO^SS||Everyman^Adam^A^^^^L^^^^^^^BS|Mum^Martha^M^^^^M| |M|| ^White^CDCREC^^^^04/24/2007|2222 Home Street^^Ann Arbor^MI^99999^USA^H||^PRN^PH^^1^555^ |^WPN^PH^^1^955^ |eng^English^ISO6392^^^^3/29/2007|M^Marrie d^HL70002^^^^2.5.1||||||N^Not Hispanic or Latino^HL70189^^^^2.5.1||||||||N||| | Reliable^ ^ISO ORC|RE|23456^EHR^ ^ISO| ^Lab^ ^ISO|||||||||1234^Admit^Alan^A^III^Dr^ ^^& ^ISO^L^^^EI^& ^ISO^^^^^^^^MD||^WPN^PH^^1^555^ |||||||Level Seven Healthcare, Inc.^L^^^^& ^ISO^XX^^^1234|1005 Healthcare Drive^^Ann Arbor^MI^99999^USA^B|^WPN^PH^^1^555^ |4444 Healthcare Drive^Suite 123^Ann Arbor^MI^99999^USA^B OBR|1|23456^EHR^ ^ISO| ^Lab^ ^ISO| ^Lead BldC- mCnc^LN^ ^Blood lead test^99USI^2.24||| ||||||diarrhea|||1234^Admit^Alan^A^III^Dr^^^& ^ISO^L^^^EI^& ^ISO^^^^^^ ^^MD|^WPN^PH^^1^555^ ||||| |||F||||||787.91^DIARRHEA^I9CDX^^^^07/09/2008|1235&Slide&Stan&S&&Dr&MD&&DOC& &ISO OBX|1|NM| ^Lead BldC-mCnc^LN^^^^2.24||50|ug/dL^micro-gram per deci-liter^UCUM^^^^1.6|<10 ug/dL|H|||F||| ||||| ||||Lab^L^^^^CLIA& &ISO^XX^^^1236|3434 Industrial Loop^^Ann Arbor^MI^99999^USA^B| ^Slide^Stan^S^^^^^NPPES& &ISO^L^^^NPI SPM|1|23456&EHR& &ISO^ &Lab& &ISO|| ^Capillary blood specimen^SCT^BLDC^Blood capillary^HL70070^ ^2.5.1||HEPA^Ammonium heparin^HL70371^^^^2.5.1|CAP^Capillary Specimen^HL70488^^^^2.5.1| ^Venous structure of digit^SCT^^^^ |||P^Patient^HL60369^^^^2.5.1|50^uL&MicroLiter&UCUM&&&&1.6||||| |